Luca Bolliger

Consumer Services

Health Technology

Finance

Profile

Mr. Luca Bolliger is a Director-Communications & Business Development at NovImmune SA. Mr. Bolliger was previously employed as Founder by Biopolo Ticino, Fundamental Analyst by BT&T Asset Management Ltd., a Member by Basel Institute for Immunology, and a Portfolio Manager by Hoffmann-La Roche, Inc. He received his undergraduate degree from the Swiss Federal Institute of Technology.

Former positions of Luca Bolliger

Companies	Position	End
Biopolo Ticino	Founder	-
BT&T Asset Management AG BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund.	Corporate Officer/Principal	-
Basel Institute for Immunology	Corporate Officer/Principal	-
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Corporate Officer/Principal	-
NOVIMMUNE SA	Public Communications Contact	-

See the detail of Luca Bolliger's experience

Training of Luca Bolliger

Swiss Federal Institute of Technology

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies